Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me. Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy? But I probably pay more attention to […]
Articles
For those of us who live in this part of the country and spend any time messing around outdoors in the grass and weeds, this is the time to be careful about Lyme disease. I had a bout of Lyme 16 years ago, and it descended on me when we were on vacation, driving through […]
Today, as part of your Friday File delightfulness, I’m taking a look at a new teaser pitch from a newsletter that I’ve never heard of before — the Radical Wealth Alliance from Investing Daily, which seems like it’s culling “ten bagger” ideas from all the Investing Daily pundits but, in this case, is pitching an […]
Cancer Care: Where Are We and Where Are We Headed?[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]
Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]
This article originally ran on January 8, 2013. It has not been updated save for the addition of this brief introductory note. More recent ad pitches on this same topic that say the stock and ticker have been “hacked” probably refer to our coverage of the story, but the more recent ads do not appear […]
This article was originally published in the Friday File for the Irregulars on November 6, and a nearly identical ad is now circulating. The article has not been updated, but the stock is essentially unchanged in price. The letter, which is an ad for The Wealth Advisory, edited by Steve Christ, teases us about a […]
Today for our Friday file we’re going to look at another teaser, this one for a biotech that’s got a performance “guarantee” from one newsletter, but I did want to share a couple thoughts first: I was just checking the performance figures of the “Idea of the Month” stocks I’ve written about so far, as […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
A couple of years ago Bristol Myers was collaborating with GERN and drove the stock to 7+ and then pulled out driving GE...
$GERN Going to look into the Geron Corp you mentioned, their shares took a huge drop last month, maybe a buying opportun...
$GERN np - Totally agree with Hedy1234. 9663 GERN, seems about once a year they say something; share price pops for a...
$GERN Dear Fr. KSS, i wanted to bring the attention to this company Geron Corp. I was wondering if you knew about it an...
pattaro $AUPH FBR's Chris Meekins says the potential for tax reform and FDA policy changes could stoke biotech M&A ...
Reader JZ wrote in requesting some guidance and coverage regarding Geron $GERN, a once-promising biotech that has underp...
$CUR Alan, Yes, I expect CUR to trade back to its pre-split AND pre-patent grant announcement price range (it's tra...
Interesting perspective on why Johnson and Johnson should purchase TransEnterix (TRXC) and Geron (GERN). http://www.f...
Yeah, Sears is a bit of a hypster. But he was the first doctor to admisister and promote TA-65, which, if you do the re...
$GERN Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes ht...
Disclosure, long Geron (GERN), which I believe is a good speculative investment and has an excellent chance of getting i...
$GERN Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Off...
Don't know if this makes a difference, but $GERN 's company name is GERON, not Genron. The fool.com article never said w...
$KBIO KalaBios Rallies Again- KalaBios Pharmaceuticals (KBIO) shares surged once again on Friday, posting gains of more...
I am in possession of one of the original gems, Geron Corp (GERN) which was supposed to have already by now given us a...
Fisherofmen: This new study will rattle Geron and imetelstat somewhat. http://www.nature.com/leu/journal/v27/n6/pdf/l...
It's been a while since I have looked in on it, and imetelstat has had some controversy. Let me look into it. May be ton...
Doc or Glenn, have y'all heard about Geron Corporation (GERN). They appeared to be a one drug (Imetelstat) company with...
Sorry for typo Geron not Genron. Cheers,Glenn...
To Booyah and others interested in Geron [GERN]: There was a great article on the Motley Fool website dated July 4, ...
Hey Tim, I've never heard of StemCells, but I do know Asterias and I did hear about them getting this money. Asterias ...
An article in SF Chronicle about stem cell therapies, and funding from the state of CA's pocketbook - $3bn set aside to ...
Elliot: the insider buying is a good point about Biotime, and yes if you are in I would stay in. I think it is an opport...
Doctor KSS, Thank you for spending some time on this one. I realize they are keeping things mysterious here, which coul...
With all of the talk about cancer, I am surprised there has been no discussion of Geron (perhaps there has been some and...
Thank you for the insight. I was searching other sources to find out why Geron was rising recently, but I was unaware of...
Travis, Does the Thinkolator have anything on the "Phoenix Event" that is offered as a free report as offered for a sub...
Welll, you dabble in the Gumshoe's business and you don't necessarily get it right. I thought that I had outsmarted Pa...
Wow...lots of off-point whining is right-sheesh. Marksman, necessity is the mother of invention-no need for population c...
Travis, You mentioned a second company Cox was intimating about. Could be Geron, as I just read an article by Cox for Sm...
Good comments. Thanks I've had Geron and PSTI for a while, and they are both up a little. I was looking at Bioti...